At a glance
ClinicalIndex Comparison RecordN/ACompleted· 300 target
Drug / intervention
Doxycycline HCI 10mg po for 2 weeks +1 moredrug
Likely dose
Doxycycline HCI 10mg po for 2 weeksfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Periodontal Care and Glycemic Control in Diabetes
In Brief
A clinical study evaluating Doxycycline HCI 10mg po for 2 weeks and Ultrasonic scaling with 0.12% chlorhexidine gluconate for Diabetes Mellitus and 2 related conditions. Completed, enrolled 300 participants across 1 site.
Detailed Summary
Diabetes is a prevalent and costly disease among users of VA care. Goals of diabetes care include the prevention and/or delay of complications via adequate glycemic control. Improvements in periodontal status may also improve diabetes control.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Poor Glycemic Control, Peridontal Disease
CountriesUnited States
CollaboratorsColgate-Periogard-Dentsply
Timeline
N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 2001
Study CompletionSep 2003
TodayJul 2026
First PostedMar 16, 2001
Study CompletionSep 1, 2003
TodayJul 2, 2026
Posted 25.3 years ago
Interventions
Doxycycline HCI 10mg po for 2 weeksdrug
Ultrasonic scaling with 0.12% chlorhexidine gluconateprocedure